Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a
complex disorder with an unknown cause. However, the dysbiosis of the gut microbiome has …

Ulcerative colitis (UC) is a common progressive inflammatory disease whose incidence has
increased rapidly in recent years, and can develop into colorectal cancer in severe cases …

Introducing specific strains of probiotics into the gut microbiome is a promising way to
modulate the intestinal microbiome to treat various health conditions clinically. However …

Pharmacological treatment of inflammatory bowel disease (IBD) is inefficient and difficult to
discontinue appropriately, and enterobacterial interactions are expected to provide a new …

Gut microbes constitute the main microbiota in the human body, which can regulate
biological processes such as immunity, cell proliferation, and differentiation, hence playing a …

In the human gastrointestinal tract, the gut mucosa and the bacterial component of the
microbiota interact and modulate each other to accomplish a variety of critical functions …

The severe and chronic inflammatory bowel diseases (IBD), Crohn disease and ulcerative
colitis, are characterized by persistent inflammation and gut damage. There is an increasing …

Clostridioides difficile (C. difficile) is progressively colonizing humans and animals living
with humans. During this process, hypervirulent strains and mutated toxin A and B of C …

Colorectal cancer (CRC) arises from aberrant mutations in colorectal cells, frequently linked
to chronic inflammation. This study integrated human gut metagenome analysis with an …

Introduction Foodborne infections, which are frequently linked to bacterial contamination,
are a serious concern to public health on a global scale. Whether agricultural farming …